FEINSOD MATTHEW (Chief Medical Officer) received a stock award from KALARIS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/18/2025ACC: 0000950170-25-041494
Officer· Chief Medical Officer
Since Mar 2026
+32.25K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
32.25K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.03K
Price / share
—
Trade value
—
% of position
New position
3/18/2025
0.00→4.03K
Total
Net shares
+4.03K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2025 | A · Award | +4.03K | — | — | New position | 0.00 | 4.03K |
| Total | +4.03K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
28.22K shares
Shares
+28.22K
Strike price
0.85
Held after
28.22K
Exercisable
—
3/18/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock28.22K shares | 3/18/2025 | A · Award | +28.22K | 0.85 | — | 28.22K |